229 related articles for article (PubMed ID: 11024409)
1. Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Whorlow SL; Krum H
Am J Cardiol; 2000 Oct; 86(8):886-9. PubMed ID: 11024409
[No Abstract] [Full Text] [Related]
2. [Economic analysis of the treatment of heart failure with beta-blockers].
Díez-Manglano J
Med Clin (Barc); 2013 Sep; 141(6):265-70. PubMed ID: 23597957
[No Abstract] [Full Text] [Related]
3. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
4. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
DiNicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH
Am J Cardiol; 2013 Mar; 111(5):765-9. PubMed ID: 23290925
[TBL] [Abstract][Full Text] [Related]
6. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
Wikstrand J; Wedel H; Castagno D; McMurray JJ
J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
[TBL] [Abstract][Full Text] [Related]
7. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis.
Lee S; Spencer A
J Fam Pract; 2001 Jun; 50(6):499-504. PubMed ID: 11401736
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
10. Major beta blocker mortality trials in chronic heart failure: a critical review.
McMurray JJ
Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV14-22. PubMed ID: 10574906
[No Abstract] [Full Text] [Related]
11. In heart failure, all beta-blockers are not necessarily equal.
Tang WH; Militello M; Francis GS
Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
[TBL] [Abstract][Full Text] [Related]
12. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
[TBL] [Abstract][Full Text] [Related]
13. Use of beta-blockers in congestive heart failure.
Sallach JA; Goldstein S
Ann Med; 2003; 35(4):259-66. PubMed ID: 12846268
[TBL] [Abstract][Full Text] [Related]
14. The impact of beta-blockade on mortality rates in patients with congestive heart failure.
Goldstein S; Gottlieb SS
J Card Fail; 2000 Jun; 6(2 Suppl 1):15-24. PubMed ID: 10908094
[TBL] [Abstract][Full Text] [Related]
15. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
[No Abstract] [Full Text] [Related]
16. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
Coats AJ
Drugs Aging; 2006; 23(2):93-9. PubMed ID: 16536633
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers for chronic heart failure: surviving longer but feeling better?
Bolger AP; Al-Nasser F
Int J Cardiol; 2003 Nov; 92(1):1-8. PubMed ID: 14602210
[TBL] [Abstract][Full Text] [Related]
19. [New milestones in the therapy of chronic heart failure with beta blockers].
Garlichs C; Daniel WG
Z Kardiol; 2000 Mar; 89(3):236-8. PubMed ID: 10798280
[No Abstract] [Full Text] [Related]
20. Beta-blocker therapy in heart failure: pathophysiology and clinical results.
Carson PE
Curr Probl Cardiol; 1999 Jul; 24(7):421-60. PubMed ID: 10403092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
